RhumbLine Advisers’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,614
| Closed | -$61K | – | 4283 |
|
|
2025
Q1 | $61K | Buy |
31,614
+5,694
| +22% | +$11K | ﹤0.01% | 3532 |
|
|
2024
Q4 | $96.9K | Buy |
25,920
+6,153
| +31% | +$23K | ﹤0.01% | 3482 |
|
|
2024
Q3 | $96.7K | Sell |
19,767
-240
| -1% | -$1.17K | ﹤0.01% | 3508 |
|
|
2024
Q2 | $150K | Buy |
+20,007
| New | +$150K | ﹤0.01% | 3378 |
|